Market Cap 14.78M
Revenue (ttm) 170,000.00
Net Income (ttm) -16.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,758.82%
Debt to Equity Ratio 0.00
Volume 33,900
Avg Vol 267,870
Day's Range N/A - N/A
Shares Out 9.01M
Stochastic %K 59%
Beta 0.94
Analysts Hold
Price Target $4.00

Company Profile

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens....

Industry: Biotechnology
Sector: Healthcare
Phone: 908 842 0100
Address:
110 Allen Road, 2nd Floor, Basking Ridge, United States
skyrockets_Inc
skyrockets_Inc Sep. 3 at 4:14 PM
$LSTA The best overall deal imo for both sides (Kuva and LSTA) would be if Kuva offers to buy the asset only and not the whole company. Kuva could offer 2 - 2.50+ upfront plus CVRS for just the asset. LSTA could then issue a special cash dividend for the up-front payment to LSTA shareholders. Then the LSTA shell can remain behind for a potential RM with a valuation of around $1/share . In doing so, total valuation for LSTA shareholders would still be in the 3.50-4.00 plus CVR range. I think this is a win-win scenario for everyone involved and hopefully is what is currently being negotiated behind the scenes.
2 · Reply
skyrockets_Inc
skyrockets_Inc Sep. 3 at 2:32 PM
$LSTA Here's my take. All opinion based on what we know and don't know. 1). I think Kuva made AN offer like they said they would by August 31. This offer most likely was not for full $4 upfront original amount, it was likely reduced. Or a completely different flavor of offer (i.e. asset sale only , license , etc). The reason I think the offer came is because I feel Kuva would have PR'd had they missed their OWN SELF DEFINED deadline of Aug 31. They would have likely released a PR saying 'we need more time'. 2). Because this 'offer' is likely not the original offer, there is probably some back and forth negotiating going on behind the scenes. Based on Lisata CEO email they are working 'several real opportunities' which likely means Reverse merger candidates. So depending on what the new Kuva 'offer' is depends on if we will hear something sooner or later. If Kuva offer is a licensing deal or asset sale we would likely hear something within weeks imo and RM would come later.
1 · Reply
LowFloatRadars
LowFloatRadars Sep. 2 at 12:19 PM
$LSTA Lets see some positive news here
0 · Reply
PyraWeb
PyraWeb Sep. 2 at 11:45 AM
$LSTA Kuva, held by MI2 Holding company….Just an FYI, but MI2 was listed as a Basking Ridge NJ based company(like LSTA) on their website. They removed that label from the website right around when the deal was going through. LSTA didn’t even have to leave town to find a “buyer”. I’m out and I don’t appreciate Mazzo, I think he’s underhanded.
0 · Reply
Rolo2024
Rolo2024 Sep. 1 at 10:36 PM
$LSTA Why the massive price swings after hours?! Volume is up some no news reported. Makes no sense.
2 · Reply
skyrockets_Inc
skyrockets_Inc Sep. 1 at 5:44 PM
$LSTA volume starting to pick up back up to levels from two weeks ago, does someone know something?
0 · Reply
j123321
j123321 Sep. 1 at 5:35 PM
$LSTA Thanks a lot for sharing this :)
0 · Reply
skyrockets_Inc
skyrockets_Inc Sep. 1 at 4:42 PM
$LSTA Kuva likely has submitted an offer to the B.O.D. already. Lisata confirmed to me via email they have no obligation to press release that Kuva submitted anything. They only have to release a PR when an offer is accepted. There is probably negotiating back and forth as well. Those that were thinking something would be released immediately on Aug 31 were mis-informed imo.
2 · Reply
WesterlyBread
WesterlyBread Sep. 1 at 4:12 PM
$LSTA I hope the guys buying today are well compensated. Congrats to them for having the stones.
0 · Reply
ikkydiphoenix
ikkydiphoenix Sep. 1 at 2:33 PM
$LSTA the reaction is not irrationa, if you release a news that you are going to ake an offer its obvious you will have to make one when you make the offert. But since they didnt it rationally means they didnt, yet.
1 · Reply
Latest News on LSTA
Lisata Therapeutics Quarterly report: Q2 2026

Aug 6, 2026, 4:00 PM EDT - 4 weeks ago

Lisata Therapeutics Quarterly report: Q2 2026


Lisata Therapeutics terminates merger with Kuva Labs

2026-07-27T14:05:15.000Z - 5 weeks ago

Lisata Therapeutics terminates merger with Kuva Labs


Lisata Therapeutics downgraded to Hold from Buy at Brookline

2026-07-27T13:55:36.000Z - 5 weeks ago

Lisata Therapeutics downgraded to Hold from Buy at Brookline


Lisata Therapeutics Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 3 months ago

Lisata Therapeutics Quarterly report: Q1 2026


Lisata Therapeutics Annual report: Q4 2025

Mar 12, 2026, 4:00 PM EDT - 5 months ago

Lisata Therapeutics Annual report: Q4 2025


Lisata Therapeutics downgraded to Hold from Buy at Brookline

2026-01-21T14:35:15.000Z - 7 months ago

Lisata Therapeutics downgraded to Hold from Buy at Brookline


Lisata Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Lisata Therapeutics Earnings Call Transcript: Q3 2025


Lisata Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Lisata Therapeutics Quarterly report: Q3 2025


Lisata Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 10 months ago

Lisata Therapeutics Earnings release: Q3 2025


Lisata Therapeutics Slides: Corporate Presentation

Nov 6, 2025, 4:00 PM EST - 10 months ago

Lisata Therapeutics Slides: Corporate Presentation


Lisata Therapeutics Slides: Corporate Presentation

Oct 21, 2025, 7:00 AM EDT - 10 months ago

Lisata Therapeutics Slides: Corporate Presentation


Lisata Therapeutics to Present at LD Micro Main Event XIX

Oct 13, 2025, 8:00 AM EDT - 10 months ago

Lisata Therapeutics to Present at LD Micro Main Event XIX


Lisata Therapeutics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Earnings Call Transcript: Q2 2025


Lisata Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Quarterly report: Q2 2025


Lisata Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Earnings release: Q2 2025


Lisata Therapeutics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Earnings Call Transcript: Q1 2025


Lisata Therapeutics Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Quarterly report: Q1 2025


Lisata Therapeutics Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Earnings release: Q1 2025


Lisata Therapeutics Slides: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Slides: Q1 2025


Lisata Therapeutics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Lisata Therapeutics Proxy statement: Proxy Filing


Lisata Therapeutics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Lisata Therapeutics Proxy statement: Proxy Filing


Lisata Therapeutics announces research license with Catalent

2025-04-15T12:11:26.000Z - 1 year ago

Lisata Therapeutics announces research license with Catalent


Lisata Therapeutics Announces Research License with Catalent

Apr 15, 2025, 8:00 AM EDT - 1 year ago

Lisata Therapeutics Announces Research License with Catalent


Lisata Therapeutics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Lisata Therapeutics Earnings Call Transcript: Q4 2024


Lisata Therapeutics Annual report: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Lisata Therapeutics Annual report: Q4 2024


Lisata Therapeutics Earnings release: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Lisata Therapeutics Earnings release: Q4 2024


Lisata Therapeutics Slides: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Lisata Therapeutics Slides: Q4 2024


Lisata Therapeutics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Lisata Therapeutics Earnings Call Transcript: Q3 2024


Lisata Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Lisata Therapeutics Quarterly report: Q3 2024


Lisata Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Lisata Therapeutics Earnings release: Q3 2024


Lisata Therapeutics Slides: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Lisata Therapeutics Slides: Q3 2024


Lisata Therapeutics Transcript: LD Micro Main Event XVI

Oct 29, 2024, 2:00 PM EDT - 1 year ago

Lisata Therapeutics Transcript: LD Micro Main Event XVI


Lisata Therapeutics Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Earnings Call Transcript: Q2 2024


Lisata Therapeutics Quarterly report: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Quarterly report: Q2 2024


Lisata Therapeutics Earnings release: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Earnings release: Q2 2024


Lisata Therapeutics Slides: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Slides: Q2 2024


Lisata Therapeutics Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Earnings Call Transcript: Q1 2024


Lisata Therapeutics Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Quarterly report: Q1 2024


Lisata Therapeutics Earnings release: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Earnings release: Q1 2024


Lisata Therapeutics Slides: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Slides: Q1 2024


Lisata Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Lisata Therapeutics Proxy statement: Proxy Filing


Lisata Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Lisata Therapeutics Proxy statement: Proxy Filing


skyrockets_Inc
skyrockets_Inc Sep. 3 at 4:14 PM
$LSTA The best overall deal imo for both sides (Kuva and LSTA) would be if Kuva offers to buy the asset only and not the whole company. Kuva could offer 2 - 2.50+ upfront plus CVRS for just the asset. LSTA could then issue a special cash dividend for the up-front payment to LSTA shareholders. Then the LSTA shell can remain behind for a potential RM with a valuation of around $1/share . In doing so, total valuation for LSTA shareholders would still be in the 3.50-4.00 plus CVR range. I think this is a win-win scenario for everyone involved and hopefully is what is currently being negotiated behind the scenes.
2 · Reply
skyrockets_Inc
skyrockets_Inc Sep. 3 at 2:32 PM
$LSTA Here's my take. All opinion based on what we know and don't know. 1). I think Kuva made AN offer like they said they would by August 31. This offer most likely was not for full $4 upfront original amount, it was likely reduced. Or a completely different flavor of offer (i.e. asset sale only , license , etc). The reason I think the offer came is because I feel Kuva would have PR'd had they missed their OWN SELF DEFINED deadline of Aug 31. They would have likely released a PR saying 'we need more time'. 2). Because this 'offer' is likely not the original offer, there is probably some back and forth negotiating going on behind the scenes. Based on Lisata CEO email they are working 'several real opportunities' which likely means Reverse merger candidates. So depending on what the new Kuva 'offer' is depends on if we will hear something sooner or later. If Kuva offer is a licensing deal or asset sale we would likely hear something within weeks imo and RM would come later.
1 · Reply
LowFloatRadars
LowFloatRadars Sep. 2 at 12:19 PM
$LSTA Lets see some positive news here
0 · Reply
PyraWeb
PyraWeb Sep. 2 at 11:45 AM
$LSTA Kuva, held by MI2 Holding company….Just an FYI, but MI2 was listed as a Basking Ridge NJ based company(like LSTA) on their website. They removed that label from the website right around when the deal was going through. LSTA didn’t even have to leave town to find a “buyer”. I’m out and I don’t appreciate Mazzo, I think he’s underhanded.
0 · Reply
Rolo2024
Rolo2024 Sep. 1 at 10:36 PM
$LSTA Why the massive price swings after hours?! Volume is up some no news reported. Makes no sense.
2 · Reply
skyrockets_Inc
skyrockets_Inc Sep. 1 at 5:44 PM
$LSTA volume starting to pick up back up to levels from two weeks ago, does someone know something?
0 · Reply
j123321
j123321 Sep. 1 at 5:35 PM
$LSTA Thanks a lot for sharing this :)
0 · Reply
skyrockets_Inc
skyrockets_Inc Sep. 1 at 4:42 PM
$LSTA Kuva likely has submitted an offer to the B.O.D. already. Lisata confirmed to me via email they have no obligation to press release that Kuva submitted anything. They only have to release a PR when an offer is accepted. There is probably negotiating back and forth as well. Those that were thinking something would be released immediately on Aug 31 were mis-informed imo.
2 · Reply
WesterlyBread
WesterlyBread Sep. 1 at 4:12 PM
$LSTA I hope the guys buying today are well compensated. Congrats to them for having the stones.
0 · Reply
ikkydiphoenix
ikkydiphoenix Sep. 1 at 2:33 PM
$LSTA the reaction is not irrationa, if you release a news that you are going to ake an offer its obvious you will have to make one when you make the offert. But since they didnt it rationally means they didnt, yet.
1 · Reply
Biotech_Pharma_Investor
Biotech_Pharma_Investor Sep. 1 at 2:20 PM
$LSTA irrational panicking. nth changed. Retail (incl me) expected news by Aug 31. Retail misinterpreting no news as lack of Kuva offer. We ll know soon
0 · Reply
WesterlyBread
WesterlyBread Sep. 1 at 2:17 PM
$LSTA Welp nevermind...
0 · Reply
WesterlyBread
WesterlyBread Sep. 1 at 1:41 PM
$LSTA Strong open considering no news...
0 · Reply
biovaluable
biovaluable Sep. 1 at 1:32 PM
$LSTA kuva again scam? Why no news?
0 · Reply
TwongStocks
TwongStocks Sep. 1 at 1:32 PM
$LSTA Assuming that Kuva was able to secure enough financing, they *should* have sent a fully funded offer to LSTA by Aug 31. 1) Was Kuva FINALLY able to secure enough financing to submit a fully funded offer for LSTA? 2) If they did, will LSTA accept the offer? I assume they will if the terms were materially similar to Kuva's most recent offer. If Kuva came in with a lower offer, but fully funded, I don't know if LSTA's board will accept it or try to find other potential deals. Wait and see for the moment.
1 · Reply
KP2021
KP2021 Sep. 1 at 1:29 PM
$LSTA 3 Promising Penny Stocks With At Least $10M Market Cap - Simply Wall St News https://simplywall.st/stocks/us/software/nasdaq-cmrc/commercecom/news/3-promising-penny-stocks-with-at-least-10m-market-cap-1
0 · Reply
Biotech_Pharma_Investor
Biotech_Pharma_Investor Sep. 1 at 7:22 AM
$LSTA no news yet. Could be an opportunity to add. But who knows. Crazy story
2 · Reply
biovaluable
biovaluable Aug. 31 at 9:29 PM
$LSTA kuva Rescam?
0 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 31 at 8:27 PM
$LSTA Update: email from LSTA CEO below "Thank you for your note; I appreciate your sentiments. I can assure you that we are progressing several real opportunities which hold the promise of returning value to shareholders. I hope that we will be able to announce something soon. Best wishes, DJM"
2 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 31 at 7:22 PM
$LSTA Both CEOs are not responding to my email as of today. They have been very quick to respond up to this point, I wonder if an offer has officially been placed....if so, will we even know? Lisata has no obligation to PR that they received an offer, only an acceptance of an offer. Place your bets.
0 · Reply
Rolo2024
Rolo2024 Aug. 31 at 5:07 PM
$LSTA Lets see what happens today! Gain or pain?! Lol
0 · Reply
Flowjob
Flowjob Aug. 31 at 12:50 PM
$LSTA Kuva website looks so shady lol They have tricked the board twice already GL
0 · Reply